MAF-funded researchers present at ISPNO 2024

The 21st International Symposium on Pediatric Neuro-Oncology was held June 28-July 2, 2024 in Philadelphia, Pennsylvania. ISPNO is the major global meeting for the international community of professionals involved in the scientific research, diagnosis, treatment, and rehabilitation of kids and teens with brain and central nervous system cancers. Doctors, researchers, and nurses you support from…


New treatment options for kids with treatment-resistant medulloblastoma

Medulloblastoma is a type of malignant brain tumor that is typically diagnosed in children and adolescents. It is one of the most common brain tumors seen in kids and accounts for 15-20% of all pediatric brain tumors. Medulloblastoma tumors usually form in the cerebellum. The cerebellum is the part of the brain that controls balance,…


Developing and improving models for testing new treatments for kids with cancer

Brain and spine tumors are one of the most common forms of cancer found in kids, second only to leukemia. Despite significant advances in treatment, brain tumors remain the leading cause of cancer-related death in children. The kids who do survive often suffer from long-term side effects from treatment, and face the risk of recurrence…


MAF-funded researchers present at ISPNO 2022

The 20th International Symposium on Pediatric Neuro-Oncology was held June 13-15, 2022 in Hamburg, Germany. ISPNO is the major global meeting for the international community of professionals involved in the scientific research, diagnosis, treatment, and rehabilitation of kids and teens with brain and central nervous system cancers. Doctors and researchers from the Morgan Adams Foundation…


Give Kids a Chance Act Aims to Expand Pediatric Cancer Research and Clinical Trials

The Give Kids a Chance Act is a bill that aims to encourage clinical trials that use combinations of drugs for kids with cancer. To date, testing new pediatric cancer treatments has not been a priority for the pharmaceutical industry because there is more potential revenue in treating adult cancers. The Give Kids a Chance…


2022 Research Funded

Thanks to the support of generous donors, 28 projects have received funding for 2022. These projects address the widest range of pediatric cancers and represent the largest single-year financial support in the history of The Morgan Adams Foundation. This groundbreaking research has the potential to change the landscape for kids with cancer. The projects are…